EVALUATION OF THE LONG-TERM IMPACT ON QUALITY AFTER THE END OF PHARMACIST-DRIVEN WARFARIN THERAPY MANAGEMENT IN PATIENTS WITH POOR QUALITY OF ANTICOAGULATION THERAPY Documento